TY - JOUR
T1 - Which patients with resectable pancreatic cancer truly benefit from oncological resection
T2 - Is it destiny or biology?
AU - Zheng, Lei
AU - Wolfgang, Christopher L.
N1 - Publisher Copyright:
© 2015 Taylor & Francis Group, LLC.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Pancreatic cancer has a dismal prognosis. A technically perfect surgical operation may still not provide a survival advantage for patients with technically resectable pancreatic cancer. Appropriate selection of patients for surgical resections is an imminent issue. Recent studies have provided an important clue on what serum biomarkers may be used to select out the patients who would unlikely benefit from the surgical resection.
AB - Pancreatic cancer has a dismal prognosis. A technically perfect surgical operation may still not provide a survival advantage for patients with technically resectable pancreatic cancer. Appropriate selection of patients for surgical resections is an imminent issue. Recent studies have provided an important clue on what serum biomarkers may be used to select out the patients who would unlikely benefit from the surgical resection.
UR - http://www.scopus.com/inward/record.url?scp=84926393186&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926393186&partnerID=8YFLogxK
U2 - 10.1080/15384047.2014.1002699
DO - 10.1080/15384047.2014.1002699
M3 - Comment/debate
C2 - 25714403
AN - SCOPUS:84926393186
SN - 1538-4047
VL - 16
SP - 360
EP - 362
JO - Cancer Biology and Therapy
JF - Cancer Biology and Therapy
IS - 3
ER -